Clinical Trial Update: A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 2 study of daratumumab in newly diagnosed multiple myeloma. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING